Results 91 to 100 of about 15,127 (212)

Smart Polymer‐Based Drug Delivery Systems for Managing Infective Conjunctivitis: Advances and Future Prospects

open access: yesNano Select, Volume 7, Issue 6, June 2026.
The introduction covers the background and significance of conjunctivitis. It continues with a review of etiology, epidemiology, and clinical manifestations. Diagnostic methods are described, followed by discussions on pathophysiology and classification. Current treatment strategies, preventive measures, and therapeutic challenges are analyzed.
Xia Linkang   +11 more
wiley   +1 more source

Relapse after oral terbinafine therapy in dermatophytosis: A clinical and mycological study

open access: yesIndian Journal of Dermatology, 2016
Background: The incidence of recurrent tinea infections after oral terbinafine therapy is on the rise. Aim: This study aims to identify the appearance of incomplete cure and relapse after 2-week oral terbinafine therapy in tinea corporis and/or tinea ...
Imran Majid   +3 more
doaj   +1 more source

Epicutaneous and Drug Provocation Testing in Severe Cutaneous Adverse Reactions: A 20‐Year Single‐Centre Experience

open access: yesContact Dermatitis, Volume 94, Issue 6, Page 677-688, June 2026.
This study provides reassuring evidence in favour of early skin testing in patients with SCARs, argues against the necessity of a 6‐month delay, and underscores the pivotal role of oral provocation tests in the safe reintroduction of essential therapies. ABSTRACT Background Identifying and discontinuing the offending drug(s) in severe cutaneous adverse
Zohra Chadli   +8 more
wiley   +1 more source

A Week of Oral Terbinafine Pulse Regimen Every Three Months to Treat all Dermatophyte Onychomycosis

open access: yesJournal of Fungi, 2019
Terbinafine has proved to treat numerous fungal infections, including onychomycosis, successfully. Due to its liver metabolization and dependency on the cytochrome P450 enzyme complex, undesirable drug interaction are highly probable.
Anarosa B. Sprenger   +3 more
doaj   +1 more source

The response of tinea capitis to treatment with a two-week oral terbinafine [PDF]

open access: yes, 2006
زمینه و هدف: درماتوفیتوز سر عبارت‌ است‌ از عفونت‌ قارچی‌ پوست‌ سر که‌ در اثر تهاجم‌ درماتوفیت‌ها به‌ ساقه‌ مو ایجاد می شود. از میان‌ درماتوفیت‌های‌ پاتوژن‌ فقط انواع‌ میکروسپوروم‌ و ترایکوفایتون‌ باعث‌آلوده‌ شدن‌ موها می شوند.
Afshari, F., Ganji, F., Moghim, H.
core  

Systemic antifungal therapy for tinea capitis in children [PDF]

open access: yes, 2016
BACKGROUND: Tinea capitis is a common contagious fungal infection of the scalp in children. Systemic therapy is required for treatment and to prevent spread. This is an update of the original Cochrane review. OBJECTIVES: To assess the effects of systemic
Abdel-Rahman   +64 more
core   +1 more source

Bilateral Ulcers in Protothecosis: A Diagnostic Challenge

open access: yes
International Journal of Dermatology, EarlyView.
Waratchaya Panjapakkul   +4 more
wiley   +1 more source

S1‐Leitlinie Infizierte Zehenzwischenraum‐Intertrigo (sogenannter „gramnegativer Fußinfekt“)

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 6, Page 832-845, June 2026.
Zusammenfassung Die infizierte Zehenzwischenraum‐Intertrigo bezeichnet eine exsudative, mazerierende oberflächliche Mischinfektion der Zehenzwischenräume, bei der gramnegative Bakterien (vor allem Pseudomonas aeruginosa, Enterobacterales) hervorstechen, aber regelmäßig auch grampositive Erreger (Staphylococcus [S.] aureus, koagulasenegative ...
Christoph Zeyen   +10 more
wiley   +1 more source

Tinea pedis: diagnosis and management

open access: yes, 2004
Tinea pedis is one of the most commonly encountered foot infections. The fact that in most cases it is easily treatable yet still prevalent in the general population suggests it is often undiagnosed or remains untreated by health care professionals and ...
Bristow, I.R.
core  

What is the most effective treatment for tinea pedis (athlete's foot)? [PDF]

open access: yes, 2002
Topical therapy is effective for tinea pedis. Topical terbinafine has a 70% cure rate, is available over the counter (OTC), and requires only 1 to 2 weeks of therapy.
Johnson, E. Diane, Markova, Tsveti
core  

Home - About - Disclaimer - Privacy